Raffaele Badolato

7PUBLICATIONS
55CO-AUTHORS
Optical technologyInnate immunityMedical virologyInfant and child healthPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 21, 2024
A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome.

Raffaele Badolato, Laia Alsina, Antoine Azar

|Jun 28, 2020
Immune response in children with COVID-19 is characterized by lower levels of T-cell activation than infected adults.

Daniele Moratto, Mauro Giacomelli, Marco Chiarini

|Apr 23, 2020
Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover.

Annarosa Soresina, Daniele Moratto, Marco Chiarini

Pageof 2